-
A Proximity MAP of RAB GTPases: Key Findings
2026-09-01
The preprint A Proximity MAP of RAB GTPases applies APEX2 proximity labeling across 23 human RAB GTPases to build a comparative map of their neighboring proteomes. Its validation of RAB25–DENND6A, RAB14–EARP, and RAB14–SHIP164/UHRF1BP1 relationships illustrates how proximity proteomics can generate testable models of membrane-trafficking regulation.
-
α2-AR Agonism in Osteosarcoma Research
2026-09-01
A translational perspective on how α2-adrenergic receptor activation may shift osteosarcoma recurrence research from direct tumor-cell killing toward immune-context engineering, with practical guidance for using B3465 in receptor, immune, and hydrogel-based studies.
-
CX-5461 Drives DNA Damage in Cervical Cancer
2026-08-31
A June 2026 study identifies a mechanistic link between Pol I transcription inhibition, DNA damage, and mitotic catastrophe in cervical cancer cells. The work also shows that CX-5461 can increase cisplatin sensitivity, supporting further investigation of ribosome-biogenesis stress as a strategy for treatment-resistant disease.
-
C34 TLR4 Inhibitor: An Assay-First Guide
2026-08-31
C34 is a selective TLR4 inhibitor for dissecting receptor-specific inflammatory signaling. This assay-first guide connects macrophage and enterocyte studies with new neuroinflammation evidence while emphasizing controls, interpretation, and translational limits.
-
Acetylspiramycin: Workflows and Resistance Insights
2026-08-30
Acetylspiramycin, or Spiramycin B, is a ribosome-directed macrolide tool for connecting susceptibility phenotypes with resistance biology and host-response experiments. This guide presents practical broth microdilution workflows, stock-handling controls, and a compartment-aware interpretation framework inspired by a published ocular infection case.
-
Naloxone hydrochloride Research Workflows
2026-08-29
Build cleaner opioid receptor, neural stem cell, immune, and behavioral assays with a single, well-characterized antagonist. This guide distinguishes receptor-dependent effects from TET1-linked neural responses and adds practical controls for concentration, solvent, timing, and interpretation.
-
CX-5461 Triggers Mitotic Catastrophe in Cervical Cancer
2026-08-28
A June 2026 study identifies a distinctive mechanism by which the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cells: DNA damage is coupled to abnormal mitotic entry, producing mitotic catastrophe, cell death, or senescence. The work also shows that CX-5461 increases cisplatin sensitivity, providing a rationale for combination strategies in treatment-resistant disease.
-
BET Inhibition in HPV-16-Associated HNSCC
2026-08-28
A bioRxiv preprint examines how BET protein inhibition alters viral and host transcription in HPV-16-associated head and neck squamous cell carcinoma. Its central finding is that BET blockade suppresses E6 and E7 but produces heterogeneous responses in p53, Rb, and viral transcription, supporting a more stratified approach to therapeutic interpretation.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-27
This guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is intended for research use with human, mouse, and rat samples, not for diagnosis, therapy, or clinical decision-making; no directly matched paper evidence was available for this specific SKU.
-
Acetylspiramycin (Spiramycin B) in Cell Assays
2026-08-27
A scenario-based guide to using Acetylspiramycin (Spiramycin B), SKU BA1075, in antimicrobial, host–pathogen, and cell viability workflows. It covers solvent compatibility, controls, assay interpretation, resistance benchmarking, and practical product-selection criteria.
-
Entecavir (BMS200475) HBV Research Workflows
2026-08-26
Entecavir (BMS200475) supports precise HBV replication studies across wild-type and lamivudine-resistant models. This workflow-focused guide covers dose-response design, DNA-polymerase readouts, formulation control, and troubleshooting for reproducible chronic hepatitis B virus replication inhibition research.
-
CB-5083: Linking p97 Inhibition to DNA Repair
2026-08-26
Explore how the p97 inhibitor CB-5083 can be used to dissect protein homeostasis disruption alongside cGAS-regulated homologous recombination. This assay-focused perspective connects mechanistic findings from naked mole-rat biology with cancer and multiple myeloma research while clearly separating evidence from hypothesis.
-
Procainamide Hydrochloride: Assay Design Guide
2026-08-25
Procainamide Hydrochloride is a cardiac sodium channel blocker with applications spanning electrophysiology and combination oncology research. This guide translates its channel pharmacology, chemical properties, and liposomal cisplatin evidence into practical assay-design decisions.
-
Rapamycin (Sirolimus): mTOR Research Workflows
2026-08-25
Build reproducible mTOR perturbation experiments with Rapamycin (Sirolimus), from nanomolar dose finding to pathway-validated cell assays. This guide also shows how the reference study’s HIF-1 and ferroptosis workflow can inform, but not replace, direct validation of rapamycin biology.
-
7-dehydro Cholesterol: A Sterol–Immunity Assay Map
2026-08-24
Explore how 7-dehydro Cholesterol and DHCR7 biology connect cholesterol biosynthesis, vitamin D3 formation, and antiviral immunity. This guide translates an in vivo grass carp study into practical decisions for sterol, UVB, skin-model, and metabolic assays.